Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.600
+0.100 (6.67%)
At close: Nov 22, 2024, 4:00 PM
1.680
+0.080 (5.00%)
After-hours: Nov 22, 2024, 7:41 PM EST
Kairos Pharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
3
Market Cap
20.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionKAPA News
- 4 weeks ago - Kairos Pharma to Present at the LD Micro Main Event XVII - GlobeNewsWire
- 6 weeks ago - Kairos Pharma to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
- 2 months ago - Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients - GlobeNewsWire
- 2 months ago - U.S. IPO Weekly Recap: 2 Microcaps List As Pipeline Gets A Big Boost - Seeking Alpha
- 2 months ago - Kairos Pharma Closing of $6.2 Million Initial Public Offering - GlobeNewsWire
- 2 months ago - Kairos Pharma Prices $6.2 Million Initial Public Offering - GlobeNewsWire
- 10 months ago - Kairos Pharma to sell 1.55 million shares in IPO at $4 each - Market Watch
- 1 year ago - Kairos Pharma Files For U.S. IPO - Seeking Alpha